Education, tips and tricks to help you conduct better fMRI experiments.
Sure, you can try to fix it during data processing, but you're usually better off fixing the acquisition!

Thursday, June 4, 2026

Might vasculo-neural coupling be the main mechanism behind tFUS neuromodulation? What does AI have to say?

 

In January I speculated on the role of blood vessels as the possible site(s) of primary activity for transcranial focused ultrasound (tFUS) neuromodulation. At the time I was unaware of vasculo-neural coupling, but in February I came across papers from 2008 and 2016 which present the hypothesis and the evidence that was available at the time. (These references, and some others, are included in a comment to the January blog post.) Since then I've been reading the literature on mechanosensitive ion channels. There is a strong basis for mechanosensitivity in compliance vessels. Whatever the mechanism(s) for tFUS, then, it is abundantly clear that vascular smooth muscle cells in arteries/arterioles and pericytes around capillaries can and do react to shear stresses arising from vasodilation/vasoconstriction. It's arguably one of their most important features in the delivery of nutrients to brain tissue.

All this got me thinking about the timing parameters of tFUS experiments, and whether the efficacy of certain timing patterns might provide useful clues on a potential causal role for blood vessels. The argument is as follows. If we know what/when/how a certain caliber of vessel responds to shear stresses during natural physiological processes, e.g. due to neurovascular coupling, to the systolic blood pressure wave each heart beat, to changes in arterial CO2 concentration, or to systemic blood pressure changes, then we might be able to predict which tFUS timing patterns are most likely to perturb a particular vessel size. Unfortunately, there doesn't seem to be a pattern, at least not to me, of whether certain pulse repetition frequencies or burst patterns reliably cause some effect. Instead, the data are all over the place, with many labs failing to reproduce effects seen elsewhere with the same (or very similar) timing patterns. I have wondered this high inter-lab variability might itself be evidence of an under-appreciated vascular mechanism, but it doesn't really point in any useful direction. What we really need is a pattern which can produce useful predictions.

So I did what any self-respecting undergraduate would do in 2026. I asked AI what it thinks. 

I began with a simple Google search. In response to search terms like "mechanosensitive ion channels time constant ultrasound," Google's AI Overview (which uses Gemini) yielded some interesting summary results such as these (edited slightly for readability):

 

Effects of ultrasound on brain tissue:

 

When a focused ultrasound pulse impacts brain tissue, it creates a minute, transient displacement (movement). Because the brain acts as a viscoelastic medium rather than a perfectly elastic one, this displacement does not happen or vanish instantaneously. The brain tissue relaxation time constant in response to an acoustic radiation force (ARF) is around 6 ms.

 

The tissue's dynamic movement is generally modeled as an overdamped system with distinct temporal constants: Rise Time Constant: approx 5.97 ms, Relaxation / Decay Time Constant: 5.94 ms.

 

Tissue displacement is linearly proportional to acoustic radiation force, which in turn is proportional to the square of the acoustic pressure.

 

Wave Displacement (Acoustic Wave): As an ultrasound wave propagates through tissue, it creates localized, microscopic movements (compression and rarefaction). For a standard acoustic wave, the amplitude of this cyclic particle displacement is directly proportional to the acoustic pressure amplitude.

 

Tissue Deformation (Radiation Force): When using concentrated, focused ultrasound to push tissues (such as in Acoustic Radiation Force Impulse or ARFI imaging), the steady, unidirectional radiation force is proportional to acoustic intensity. Because acoustic intensity is proportional to the square of acoustic pressure, the resulting localized tissue displacement is also proportional to the square of the acoustic pressure.

 

In brain tissue, acoustic radiation force and resulting mechanical displacements scale linearly with ultrasound frequency and quadratically with pressure. This linear frequency dependency is primarily driven by how ultrasound attenuation (absorption) increases with higher frequencies, causing more momentum transfer per unit volume.

 

The core relationship for the force per unit volume of tissue (FARF) is:

 

FARF = 2.alpha.I / c0

 

Where:

  • alpha: The tissue-specific ultrasound attenuation coefficient, which follows a power-law relationship with frequency (f).
  • I: The local acoustic intensity.
  • c0: The speed of sound in the brain tissue.

 

Because alpha is heavily dependent on the carrier frequency (generally increasing linearly with f in the 0.5 to 5 MHz range), using a higher frequency ultrasound inherently generates a stronger localized pushing force, yielding larger micrometer-scale tissue displacements.

Typical displacements of brain tissue are around 1-10 microns.

 

This is a pretty good summary of what I'd already gleaned from reading tFUS review articles. It's interesting for the tissue response, but it doesn't relate to any potential vascular response. So I added "brain arteries" to my search, yielding these further insights: 

 

Mechanosensitivity of brain vasculature:

 

Mechanosensitive ion channels in cerebral arteries govern the myogenic response and neurovascular coupling. Because these proteins gate via physical membrane stretch rather than voltage, their operational kinetics vary widely.

 

The underlying time constants (tau) governing channel activity and subsequent arterial changes include:

 

  • Channel Opening and Inactivation: Conformational changes (gating) for mechanosensitive channels like PIEZO1/2 or TRP channels (e.g., TRPC6, TRPM4) typically occur in the microsecond to millisecond range. Inactivation time constants can range from a few milliseconds for rapid adaptation to ~350 ms for sustained desensitization.
  • Intracellular Calcium Signaling: The electrical depolarization from mechanosensitive channel ion flux (Na+, Ca2+) triggers voltage-gated calcium channels. The time constant for the resulting intracellular calcium elevation generally ranges from 0.3 to 4 seconds.
  • Myogenic Arterial Constriction: The physical contraction of the vascular smooth muscle downstream of channel activation occurs on a macroscopic level, typically presenting with an overall time constant of 10 to 30 seconds in computational models, though rapid dynamic adjustments for cerebral autoregulation as a whole can finalize within 3 to 5 seconds.


Key Channel Families in Cerebral Arteries:

 

  1. PIEZO1 / PIEZO2: Essential non-selective cation channels in CNS capillaries and brain cortex endothelium that translate blood flow shear stress and mechanical stretch into calcium signals.
  1. TRP (Transient Receptor Potential) Channels: Channels like TRPC6 and TRPM4 are prominent in vascular smooth muscle cells, playing a critical role in sensing mechanical wall tension to initiate depolarization and maintain myogenic tone.
  1. ASIC (Acid-Sensing Ion Channels): Specifically ASIC1/ASIC2, which function via tether-gate spring mechanisms to facilitate mechanosensitivity in vascular cells.
 

Perhaps unsurprisingly, these dynamics are reminiscent of the standard BOLD response in fMRI. Perhaps, then, any tFUS timing parameters sensed by arteries might resemble the slow dynamics of a typical task fMRI experiment. For a tFUS paradigm which uses, say, 350 kHz fundamental ultrasound frequency, a pulse repetition rate of 120 Hz in blocks of 100 ms five times a second over a minute, it would be the blocks (5 Hz) and total envelope (0.0167 Hz) that involve frequencies which fall in the window of the slow time constants mentioned by Google. Furthermore, if the arterial response acts as a low-pass filter to the ultrasound parameters, as neurovascular coupling does for fMRI, might it be that some published tFUS experiments inadvertently used lower frequencies in bursts or envelopes that are sensed by mechanosensitive ion channels in arteries or capillaries? I quickly reviewed a dozen tFUS papers for signs of greater neuromodulation from the lower frequencies used in block lengths or total trial durations, but no obvious patterns stood out.

At this point I was somewhat satisfied that if tFUS does activate arteries directly, it might follow timing that's typical for an event-related task fMRI experiment. Except that I kept on coming back to the 6-ms time constant for tissue displacements produced by the acoustic radiation force. For a 6-ms pulse of ultrasound followed by a 6-ms delay for relaxation, a larger frequency of around 83 Hz (1/0.012 ms) could be relevant. Again, none of the published tFUS studies yielded a clear pattern whereby pulse repetitions at ~80 Hz generated larger responses than other rates. And this got me thinking more deeply about the way ultrasound waves produce shear in vessels versus tissue.

This time I changed AI agent. Claude has been helpful in earlier academic questions I've had. And Claude did not disappoint. Correct or not, the responses have given me a vast amount to think about. So, without further ado, here is that conversation in its entirety, with my five questions highlighted yellow to allow you to relocate quickly. I'll do a brief summary of my current thinking at the very end of the post.

 

Me:   I'm trying to devise a model for the interaction of low intensity ultrasound with mechanosensitive ion channels in the smooth muscle cells and/or pericytes of arteries, arterioles and capillaries in the brain - that is, the compliance vessels - with the specific intention of timing the ultrasound pulses for the greatest response. What properties of the arteries/arterioles should I be taking into account, and why? And based on these properties, what ultrasound timing parameters are suggested?

Claude:   This is a genuinely fascinating and technically rich problem — optimising ultrasound pulse timing for mechanosensitive channel (MSC) activation in cerebrovascular compliance vessels requires integrating vascular biomechanics, cell biology, and acoustic physics. Here is a structured breakdown:

Relevant Properties of Compliance Vessels and Why They Matter

1. The Cardiac Cycle and Vessel Wall Strain

The most fundamental timing anchor is the cardiac pulse wave. Cerebral arteries and arterioles undergo cyclic strain of roughly 5–15% circumferential stretch per heartbeat. Mechanosensitive channels — particularly Piezo1, TRPV4, TRPC6, and MscL homologues in smooth muscle cells and pericytes — are strain-gated. Their open probability rises steeply with membrane tension according to a Boltzmann relationship.

Implication: Ultrasound-induced acoustic radiation force or oscillatory shear will sum with, or oppose, the existing wall stress. Delivering pulses during peak systolic distension (when the membrane is already near threshold) requires less acoustic energy for MSC activation. Delivering at diastolic minimum may still be useful if you want to exploit the rate of change of tension (channel kinetics respond to tension velocity as well as magnitude).

2. Vessel Wall Viscoelasticity and Compliance

Cerebral resistance vessels have a highly nonlinear stress-strain curve (stiffening at high strain) and pronounced viscoelastic hysteresis. The relaxation time constant of the wall (typically 100–500 ms in small arteries, shorter in capillaries) determines how quickly residual stress decays after an imposed deformation. Pericytes on capillaries act as discrete contractile nodes rather than a continuous sheet, so the local compliance varies substantially along the vessel. 

Implication: Ultrasound pulse bursts should be shorter than the wall relaxation time if you want to summate mechanical stimuli (like temporal summation). If bursts are longer, the vessel re-equilibrates and subsequent cycles feel the same baseline tension. An optimal burst duration is likely in the range of 50–200 ms for arterioles, shorter for capillaries.


3. Myogenic Tone and Autoregulation State

The cerebral vasculature has strong myogenic tone — smooth muscle cells are partially contracted at rest, and their membrane potential sits around −40 to −50 mV, substantially depolarised relative to a passive cell. 

This means:

  • MSCs are already partially active
  • The cell is close to the threshold for voltage-gated Ca²⁺ channel (CaV1.2) activation
  • Modest additional stretch-activated current can trigger a full action potential or Ca²⁺ spark 

Implication: The myogenic state is a crucial multiplier for your stimulus. At normal cerebral perfusion pressure (~70–80 mmHg), the gain is maximised. At very high or very low pressure, autoregulation saturates and cells are maximally contracted or maximally relaxed, reducing responsiveness. Timing relative to autoregulatory state may matter more than exact cardiac phase in some pathological contexts.

4. Resonant Frequency of the Vessel Wall

Vessel walls have mechanical resonances. For a cylindrical elastic tube, the lowest resonant frequency is approximated by: 

f₀ ≈ (1/2π) × √(Eh/ρR²) 

where E is wall elastic modulus, h is wall thickness, ρ is density, and R is lumen radius. For cerebral arterioles (R ~ 50–150 μm, h ~ 10–25 μm, E ~ 10–100 kPa), this gives resonances in the range of hundreds of Hz to low kHz — far below typical diagnostic ultrasound frequencies but potentially reachable with low-frequency burst modulation envelopes. 

Implication: If the ultrasound carrier is amplitude-modulated at or near this resonant frequency, the vessel wall will preferentially amplify the oscillatory strain. This is conceptually similar to how lithotripsy pulses are timed to stone resonance. Modulation frequencies of 100–500 Hz are worth exploring for arterioles; capillaries with stiffer, thinner walls (and pericyte stiffness dominating) may have higher resonances. 

5. MSC Gating Kinetics

Piezo1 channels have:

  • Activation time constants of ~1–5 ms
  • Inactivation time constants of ~10–100 ms (variable, tension-dependent)
  • Recovery from inactivation: ~100–500 ms

TRPV4 (highly expressed in pericytes and endothelium) gates more slowly and is also sensitive to osmotic and thermal gradients, meaning it integrates mechanical stimuli over longer windows. 

Implication: For Piezo1 targeting, pulse repetition frequencies (PRF) should ideally be 2–10 Hz (allowing full recovery between pulses) or much higher (>100 Hz) to exploit incomplete inactivation for summation before the channel fully closes. For TRPV4, slower protocols with longer dwell times per burst are more appropriate. 

6. Cerebrovascular Pulsatility Index and Phase

The pulsatility index (PI) (Gosling index: (systolic − diastolic velocity) / mean velocity, typically 0.6–1.1 in the MCA) reflects the pressure waveform transmitted to downstream vessels with a measurable phase delay. The pulse transit time from large arteries to arterioles is ~20–50 ms, and to capillaries potentially ~50–100 ms. If targeting small resistance vessels specifically, the ultrasound pulse must be timed to the local pressure peak, not the carotid or ECG R-wave. 

Implication: You need a phase-correction offset from your cardiac synchronisation trigger. For pericytes on capillaries, this offset may be 80–120 ms post-R-wave, depending on individual vascular geometry and blood pressure. 

7. Acoustic Properties of the Blood–Wall Interface

The acoustic impedance mismatch at the blood–wall interface creates partial standing wave effects. The vessel wall's absorption coefficient at low-frequency ultrasound (0.5–3 MHz) is relatively low, meaning most energy passes through. However, at vessel diameters comparable to the ultrasound wavelength, Mie scattering becomes relevant, and the radiation pressure on the wall becomes geometry-dependent. At 1 MHz, λ ≈ 1.5 mm in tissue — much larger than arterioles, so they sit in the Rayleigh scattering regime and experience radiation force proportional to vessel volume and acoustic intensity gradient. 

Implication: The coupling of acoustic energy to wall strain is weak per-pulse for small vessels. You compensate by pulse repetition rather than intensity, keeping mechanical index (MI) low (target MI < 0.4) to avoid cavitation. Long duty cycles at low intensity are mechanistically preferable to short high-intensity bursts for MSC engagement. 

Suggested Ultrasound Timing Parameters

Synthesising the above:

 
 

Key Uncertainties and Open Questions

  1. Which MSC type dominates the functional response? Piezo1 in SMCs drives constriction via Ca²⁺ influx; TRPV4 in pericytes and endothelium may drive dilation via NO and K⁺ channel coupling. Your timing optimum will differ depending on which target you prioritise.
  2. Neurovascular coupling state — astrocyte endfeet ensheathing pericytes are themselves mechanosensitive and modulate pericyte tone. The network-level response may not be predictable from single-cell MSC models.
  3. Standing wave formation in the skull — transcranial delivery creates interference patterns that modulate local intensity at vessel locations in ways that are geometry-dependent and hard to model without subject-specific simulations.
  4. In vivo validation of the wall resonance hypothesis is sparse; most data comes from in vitro tube models or ex vivo preparations where tone and geometry differ from the living state.

A productive modelling approach would be to build a coupled viscoelastic tube + Boltzmann MSC gating model, driven by a realistic cerebral pressure waveform, with acoustic forcing added as a time-varying wall stress term, then optimise timing parameters for integrated MSC open probability over a cardiac cycle.

 

Me:   You mentioned the acoustic radiation force a couple of times. I understand that brain tissue has a response time constant to ARF of around 6 ms. Is this time constant relevant to the response in arteries, arterioles or capillaries?

Claude:   Great question — and the answer is nuanced, because that ~6 ms time constant you're referring to applies to a specific physical context that is not directly applicable to vessel walls, though it informs your thinking in important ways.

What the ~6 ms Time Constant Actually Represents

 

The ~6 ms figure comes from ARFI (Acoustic Radiation Force Impulse) imaging studies of bulk brain parenchyma — it is the viscoelastic creep/recovery time constant of the brain tissue matrix responding to a step-change in radiation force. It reflects:

  • The shear viscoelasticity of the parenchyma (predominantly the extracellular matrix, neuropil, and glial network)
  • Tissue displacement on the order of 1–10 μm in response to focused ultrasound pushing
  • Recovery governed by the shear modulus (~2–10 kPa for brain) and viscosity (~2–8 Pa·s)

 

This is essentially bulk tissue mechanics — it tells you how fast the parenchyma as a whole creeps under a sustained radiation force and then springs back.

 

Is It Relevant to Vessel Walls Specifically?

 

Short answer: only indirectly — and there are several important distinctions.

 

1. The Vessel Wall Is a Pressurised Tube, Not a Bulk Solid

 

A cerebral arteriole or artery under physiological transmural pressure (mean ~60–80 mmHg, pulsatile) is a circumferentially pre-stressed structure. Its effective dynamic stiffness is dominated by:

  • Intraluminal pressure (the dominant restoring force for radial displacement)
  • Smooth muscle tone (which can vary the effective modulus by an order of magnitude)
  • Wall elasticity (elastin + collagen + actin-myosin network)

 

The restoring force per unit displacement is much higher than for surrounding parenchyma, meaning the vessel wall's own relaxation time constant is shorter — roughly 0.5–5 ms for the radial breathing mode of a pressurised arteriole, compared to 6 ms for surrounding tissue.

 

2. The Surrounding Parenchyma Couples to the Vessel Wall

 

Here the 6 ms figure does become relevant — as a coupling constraint. The vessel is embedded in, and mechanically coupled to, the brain parenchyma. When ARF displaces the vessel:

  • The vessel wall moves with a fast time constant (sub-ms to ~2 ms)
  • But the surrounding tissue resists and lags with its ~6 ms time constant
  • The net displacement of the vessel wall is therefore a convolution of both responses

 

This means the parenchymal time constant acts as a low-pass filter on vessel displacement. Rapid ARF pulses (< 6 ms) will partially be absorbed by vessel wall compliance before the surrounding tissue has fully responded, potentially enhancing the differential strain across the wall — which is precisely what drives MSC gating.

 

3. Perivascular Space Modifies the Coupling

 

Cerebral arteries and arterioles are surrounded by the Virchow-Robin perivascular space — a fluid-filled annular gap between the vessel wall and the glia limitans. This space:

  • Decouples the vessel from direct parenchymal mechanical loading over short timescales
  • Has its own fluid dynamic response time (the perivascular fluid can be displaced by vessel wall motion on a timescale of ~1–10 ms, depending on vessel calibre and space dimensions)
  • Means the vessel is more mechanically isolated than a vessel embedded directly in a solid matrix

 

For capillaries, which lack a true perivascular space and are directly apposed to astrocyte endfeet, the coupling to parenchymal mechanics is tighter, making the 6 ms constant more directly relevant to pericyte displacement.

 

4. Distinct Time Constants by Vessel Calibre


 
 

5. Implications for ARF Pulse Timing

 

Given this, the 6 ms parenchymal time constant suggests specific pulse design considerations:

  • Pulse duration < 6 ms (e.g., 1–3 ms): The vessel wall is displaced faster than the surrounding parenchyma can respond, maximising differential wall strain and therefore MSC gate-opening probability. This is likely optimal for Piezo1 in arteriolar SMCs.
  • Pulse duration ≈ 6 ms: The parenchyma and vessel wall reach quasi-static equilibrium together — less differential strain, but maximal absolute displacement of the whole vessel. May be relevant for pericytes that are directly mechanically coupled to the matrix.
  • Pulse duration >> 6 ms (e.g., 10–50 ms): The parenchyma has fully crept, the vessel has re-equilibrated, and you're in the domain of sustained ARF — here the myogenic response time constant (~100–500 ms) becomes the limiting factor for SMC response, and the 6 ms figure is no longer limiting.
  • Interpulse interval: Should be ≥ 6 ms (and ideally ≥ the vessel wall recovery time constant) to allow full mechanical recovery before the next pulse contributes additive strain. For Piezo1 recovery (100–500 ms), this is the longer constraint that dominates. 

 

Summary

 

The ~6 ms parenchymal ARF time constant is not directly the relevant time constant for vessel wall MSC activation, but it matters as:

  1. A coupling filter between the acoustic field and vessel wall displacement (most important for capillaries and pericytes)
  2. A design target — pulses shorter than 6 ms maximise differential strain across the vessel wall relative to surrounding tissue
  3. A floor on interpulse spacing for mechanical recovery, though MSC inactivation kinetics (longer) will usually dominate this constraint

 

The vessel wall's own radial time constants (sub-ms to ~5 ms depending on calibre and tone) are the more direct parameters governing how fast the wall actually deforms in response to ARF, and these should be the primary targets for pulse duration optimisation aimed at MSC gating.

 

Me:   I want to look at the timing and duration of focused ultrasound applied to the brain for evidence that the mechanism(s) behind neuromodulatory effects might originate in arteries/arterioles/capillaries and affect neural signaling via vasculo-neural coupling, rather than the conventional view of neuro-vascular coupling. Assessment with appropriate behavioral tasks or TMS suggest that the neuromodulatory effects of focused ultrasound last for minutes to tens of minutes. Does this latency favor a vasculo-neural mechanism over a neuron-first neuro-vascular mechanism?

Claude:   This is a really sharp mechanistic question, and the answer is — yes, the temporal profile of FUS neuromodulation is substantially more consistent with a vasculo-neural mechanism than a neuron-first mechanism, for several converging reasons.

What the Timescales Actually Tell Us

 

The Core Problem with a Neuron-First Interpretation

 

If FUS were acting directly on neurons — via membrane capacitance changes, intramembrane cavitation (the Krasovitski/Plaksin sonophore model), or direct mechanosensitive channel activation on the neuronal membrane — you would expect:

  • Onset: within milliseconds of the pulse (neuronal membrane time constants are 1–20 ms)
  • Duration: decaying within seconds to tens of seconds at most, governed by synaptic plasticity time constants (LTP/LTD induction aside)
  • Offset: rapid, following the acoustic stimulus closely unless secondary synaptic remodelling is invoked

 

What is actually observed is:

  • Onset latency: often hundreds of milliseconds to seconds after stimulus onset
  • Duration: minutes to tens of minutes post-stimulus
  • Gradual return to baseline: not a sharp offset

 

This temporal profile does not match direct neuronal membrane physics. It requires invoking secondary messenger cascades or network-level remodelling to explain it in a neuron-first framework — which is possible but adds explanatory layers that a vasculo-neural model does not need.

 

Why Vasculo-Neural Coupling Fits Better

 

1. Vascular Smooth Muscle and Pericyte Response Timescales Match

 

The myogenic response to a mechanical stimulus in cerebral arterioles develops over seconds to tens of seconds and can be sustained for minutes as long as the triggering condition persists or a calcium-mediated contractile state is maintained. Pericyte contraction/relaxation similarly operates on a seconds-to-minutes timescale.

 

A single FUS burst could trigger MSC-mediated Ca²⁺ influx in SMCs or pericytes, initiating a contractile or relaxation response that:

  • Alters local cerebral blood flow (CBF) and oxygen delivery
  • Changes perivascular space dimensions and CSF/ISF flow
  • Modulates extracellular K⁺, adenosine, and lactate concentrations in the neuropil

 

These vascular changes would persist for minutes after the acoustic stimulus ends — because vascular tone is governed by slow biochemical feedback loops (Ca²⁺/calmodulin/MLCK, RhoA/ROCK, NO signalling), not fast electrical time constants.

 

2. Neurovascular Coupling Is Bidirectional — The Vasculo-Neural Direction Is Underappreciated

 

The conventional model treats neural activity as the cause and vascular response as the effect. But there is substantial evidence for the reverse:

  • Perivascular neurotransmitter release: SMC and pericyte tone modulates extracellular adenosine and ATP, both of which are neuroactive. Adenosine in particular is a powerful modulator of neuronal excitability (A1 receptors are inhibitory, A2A receptors are excitatory) and operates on exactly the minutes timescale seen in FUS effects
  • K⁺ spatial buffering: Changes in arteriolar diameter alter astrocyte endfeet stretch, modulating Kir4.1-mediated K⁺ buffering capacity, which in turn shifts neuronal excitability
  • Nitric oxide: Endothelial NO released in response to vascular mechanical stimulation diffuses into the neuropil and modulates neuronal excitability and synaptic strength — NO has a diffusion radius of ~100–300 μm and a biological half-life of seconds to minutes
  • Glymphatic flow: Changes in perivascular space driven by arteriolar pulsatility alterations would modify ISF composition (clearing glutamate, K⁺, metabolites) on a timescale of minutes to tens of minutes — matching the observed FUS effect duration precisely

 

3. The Adenosine Hypothesis Is Particularly Compelling

 

This deserves special attention. FUS-induced vascular effects could elevate extracellular adenosine via:

  1. ATP release from mechanically stimulated endothelium or SMCs (well established)
  2. Ecto-nucleotidase conversion of ATP → ADP → AMP → adenosine
  3. Hypoxic adenosine release if FUS transiently reduces CBF via vasoconstriction

 

Adenosine acting on neuronal A1 receptors produces:

  • Membrane hyperpolarisation (increased GIRK conductance)
  • Reduced synaptic vesicle release probability
  • Suppression of excitatory transmission

 

This is exactly the inhibitory neuromodulatory profile seen in many FUS studies. Critically, adenosine-mediated inhibition can persist for 5–20 minutes following a transient ATP release event — because adenosine clearance is rate-limited by adenosine kinase and deaminase activity, and re-uptake is saturable.

 

If FUS instead directly activated neuronal mechanosensitive channels, you would expect an initial excitatory response followed by rapid adaptation — not sustained inhibition lasting tens of minutes.

 

4. TMS Evidence Is Particularly Telling

 

TMS-based assessments (measuring cortical excitability via motor evoked potential amplitude, or inhibitory/excitatory ratios via paired-pulse protocols) show FUS-induced changes persisting 10–40 minutes post-stimulus. These timescales are:

  • Consistent with: vascular tone changes → sustained alteration of neurovascular unit microenvironment → shifted neuronal excitability set-point
  • Inconsistent with: direct neuronal mechanotransduction, which would not sustain altered excitability for this duration without invoking LTP/LTD — and LTP/LTD induction by FUS has not been convincingly demonstrated at the stimulus parameters used in neuromodulation studies

 

Furthermore, the spatial specificity reported in some TMS studies (effects localised to the targeted cortical area) is consistent with a vascular mechanism, since arteriolar territories have defined spatial domains. A purely neuronal mechanism would be expected to propagate rapidly via axonal and synaptic networks beyond the sonicated volume.

 

5. Comparison with Known Vasculo-Neural Phenomena

 

Several established physiological and pharmacological phenomena produce neuromodulatory effects via vascular mechanisms, and their timescales are instructive:

The FUS timescale slots naturally into the vasculo-neural column, not the direct neuronal column.

 

The Strongest Counterargument

 

To be fair, the neuron-first camp can invoke network-level reverberant activity — initial direct neuronal activation by FUS triggering recurrent excitation/inhibition loops that sustain altered excitability states long after the stimulus. GABA interneuron modulation in particular can produce sustained changes in E/I balance lasting minutes. This is a legitimate mechanism that cannot be excluded.

 

However, this predicts an initially excitatory response that then evolves — whereas many FUS studies show either purely inhibitory responses or inhibition with a very short initial excitatory transient. A vasculo-neural mechanism via adenosine or glymphatic modulation more naturally explains predominantly inhibitory, slowly-developing, long-lasting effects.

 

Summary Assessment

 

The latency and duration profile of FUS neuromodulation does favour a vasculo-neural mechanism as the primary driver, because:

  1. The timescale (minutes) matches vascular tone dynamics, adenosine signalling, and glymphatic flow modulation — not neuronal membrane physics
  2. The spatial confinement of effects matches arteriolar territory domains
  3. The predominantly inhibitory character matches adenosine/K⁺ buffering effects, not direct mechanosensitive channel activation on neurons
  4. No additional explanatory machinery (LTP/LTD, reverberant networks) is needed — Occam's razor favours the vascular route
 

The field's default assumption of a neuron-first mechanism may reflect the historical framing of neurovascular coupling rather than the weight of the temporal evidence.

 

Me:   And is there any evidence against focused ultrasound perturbing arteries/arterioles/capillaries directly as the first step in neuromodulation?

Claude:   This is the right critical question to ask before building too much on the hypothesis. The honest answer is that the evidence against is surprisingly weak and largely indirect — but it does exist and deserves serious engagement.  

Arguments That Have Been Made Against a Vascular-First Mechanism

 

1. FUS Effects Have Been Observed in Preparations Without Intact Vasculature

The most direct challenge comes from in vitro studies showing FUS-induced changes in neuronal firing in dissociated cell cultures or acute brain slices — preparations where functional vasculature is absent or non-perfused.

However, this objection is weaker than it first appears:

·       Brain slice preparations retain vessel wall fragments and isolated SMC/pericyte processes, which could still respond to ARF

·       Dissociated cultures show FUS effects at intensities often considerably higher than used in in vivo neuromodulation — possibly engaging different mechanisms

·       The absence of perfusion pressure means any vascular remnants lack myogenic tone, removing the most important multiplier for MSC sensitivity discussed earlier

·       These preparations cannot speak to what happens in vivo at low intensities under physiological perfusion conditions

2. The Temporal Precision Argument

Some studies report FUS effects on neural activity with millisecond-scale precision — for example, phase-locking of neural oscillations to the ultrasound pulse envelope, or suppression of specific TMS-evoked components with short latency.

If effects were purely vascular-first, you would not expect millisecond-scale neural entrainment, since vascular tone changes are too slow.

Counterpoint:

·       Millisecond-scale entrainment and minutes-long neuromodulation are not mutually exclusive — there could be a fast direct neuronal component and a slow vascular component operating in parallel

·       The fast component might contribute little to the sustained neuromodulatory effect measured behaviourally or by TMS, even if it is the most visible in electrophysiology

·       Rapid oscillatory ARF at the pulse repetition frequency could entrain perivascular neural plexuses (sympathetic/parasympathetic innervation of vessel walls) rather than cortical neurons directly

3. Neuromodulation Has Been Reported Below the Threshold for Detectable Hemodynamic Change

Some fMRI and fUS (functional ultrasound) studies report FUS neuromodulatory effects at parameters that do not produce measurable BOLD signal changes or detectable CBF alterations.

This is perhaps the strongest argument against a vascular-first mechanism — if the vasculature were the primary transducer, you might expect some hemodynamic signature.

However, several important caveats apply:

·       BOLD fMRI has a temporal resolution of seconds and spatial resolution of millimetres — it would miss focal arteriolar tone changes in small resistance vessels that do not propagate to a detectable CBF alteration

·       Functional ultrasound imaging is more sensitive but still has spatial and temporal limits at the capillary/arteriolar level

·       A balanced vasoconstriction/vasodilation response (e.g., upstream arteriolar constriction with downstream capillary dilation) could produce net zero CBF change while still substantially altering neurovascular unit microenvironment

·       Adenosine and K⁺ release from mechanically stimulated vascular cells could alter neuronal excitability without requiring a sustained CBF change detectable by imaging

4. Pharmacological Dissection Studies

A small number of studies have attempted to block vascular responses pharmacologically and tested whether FUS neuromodulation persists. If it does, this argues against a vascular-first mechanism.

The honest assessment here is that this literature is very thin. There are no clean, well-powered studies that have:

·       Selectively blocked cerebrovascular MSCs (Piezo1/TRPV4) pharmacologically

·       Confirmed the block was complete in the target vessels

·       Demonstrated preserved FUS neuromodulation

The pharmacological tools for selective in vivo blockade of cerebrovascular MSCs are themselves limited — most available blockers (GsMTx4 for Piezo channels, GSK2193874 for TRPV4) have incomplete CNS penetration or off-target effects on neuronal channels. This is essentially an untested prediction of the vascular-first hypothesis, which cuts both ways — absence of evidence is not evidence of absence.

5. The Skull and Targeting Argument

Some researchers argue that FUS beams targeting deep structures show neuromodulatory effects with spatial specificity inconsistent with the vascular distribution — implying direct neural targeting rather than vascular.

This argument is weak for the following reasons:

·       Cerebrovascular architecture closely follows neural architecture — arteriolar territories map onto cortical columns and subcortical nuclei with considerable spatial fidelity

·       The spatial resolution of FUS (especially transcranial) is limited by skull aberration to millimetres — comparable to arteriolar territory dimensions

·       There is no demonstrated case where FUS neuromodulation has been spatially dissociated from the underlying vascular territory

6. Thermal Arguments

At some parameter sets, FUS may produce small but non-negligible temperature rises (< 1°C) in the target tissue. Neurons are thermosensitive (TRPV1, TRPV4, temperature-sensitive K⁺ channels), and it has been argued that mild heating directly modulates neuronal activity.

Against a vascular-first interpretation, mild heating would vasodilate rather than trigger the MSC-mediated contractile response that would most potently alter vascular tone.

However:

·       Thermal effects at neuromodulatory parameter sets are generally agreed to be too small to explain the observed neuromodulation magnitude

·       Mild heating of vascular endothelium triggers NO release and prostacyclin production — both vasoactive and neuroactive — so thermal effects on vasculature cannot be cleanly separated

·       Temperature rises at the vessel wall from ARF absorption may be locally higher than bulk tissue measurements suggest


What Is Notably Absent from the Evidence Against

It is worth being explicit about what has not been shown:

·       No study has demonstrated FUS neuromodulation that requires direct neuronal mechanotransduction and is abolished by vascular blockade

·       No study has shown that neurons in the FUS target express mechanosensitive channels at densities sufficient to account for the observed effects at the acoustic intensities used — neuronal Piezo1 expression in the adult cortex is low compared to vascular cells

·       No study has convincingly excluded a vascular contribution using methods sensitive enough to detect arteriolar and capillary-level changes

 

The Deeper Problem: The Field Has Not Been Looking

Perhaps the most important point is that the experimental paradigm has been systematically biased toward finding neuronal mechanisms. Studies have used:

·       Electrophysiology (measures neurons, not vessels)

·       BOLD fMRI (insensitive to small vessel changes)

·       Calcium imaging in neurons (not in SMCs or pericytes)

Almost no published FUS neuromodulation studies have used:

·       Two-photon imaging of arteriolar diameter during and after FUS

·       Pericyte calcium imaging with simultaneous neural recording

·       Perivascular adenosine biosensors

·       Glymphatic tracer clearance assays with FUS timing

The absence of evidence against the vascular-first hypothesis is therefore substantially a consequence of the absence of experiments designed to test it. This is arguably the field's most significant blind spot.

 

Summary

 
 

The evidence against a vascular-first mechanism is real but not strong, and importantly, the critical experiments to definitively test the hypothesis have largely not been performed. The field's neuron-centric experimental toolkit has created a systematic blind spot. The vascular-first hypothesis remains not just viable but arguably under-tested relative to its plausibility.

 

Me:   If focused ultrasound did produce neuromodulation via a vasculo-neural coupling mechanism which originates in the arteries, arterioles and/or capillaries, would the vascular response act like a low pass filter on the focused ultrasound timing parameters?

Claude:   Yes — and this is a really elegant way to frame it, because it makes a set of testable quantitative predictions that could distinguish vasculo-neural from neuron-first mechanisms. The vascular system would indeed act as a low-pass filter, but it is a multi-stage, nonlinear filter with several distinct cutoff frequencies depending on which vascular compartment and which downstream signalling pathway you are considering.

The Filter Stages

Stage 1: Acoustic Radiation Force → Vessel Wall Displacement

This is the fastest stage. The vessel wall responds to ARF mechanically with time constants of sub-millisecond to ~5 ms as discussed previously. As a filter this stage has a relatively high cutoff — it can follow rapid changes in acoustic intensity reasonably faithfully up to perhaps 200–1000 Hz modulation frequencies before the wall mechanics begin attenuating the displacement amplitude.

This stage is not strongly low-pass for typical FUS parameters — the vessel wall is fast enough to track the pulse envelope fairly well.

Stage 2: Vessel Wall Displacement → MSC Gating

Piezo1 activation and inactivation kinetics impose the next filter stage:

·       Activation: ~1–5 ms → upper cutoff ~200 Hz

·       Inactivation: ~10–100 ms → this is where low-pass behaviour first becomes significant

·       Recovery from inactivation: ~100–500 ms → cutoff ~2–10 Hz

This stage acts as a rectifying low-pass filter — it responds to the envelope of mechanical stimulation rather than individual cycles, and it cannot follow pulse repetition frequencies much above ~2–10 Hz without accumulating inactivation. Rapid pulse trains above this frequency will produce a saturating, sustained Ca²⁺ influx rather than discrete gated responses — which is itself a form of low-pass conversion from a pulsed input to a tonic output.

Stage 3: MSC Gating → Intracellular Ca²⁺ in SMC/Pericyte

Ca²⁺ dynamics in smooth muscle cells impose another filter stage with multiple time constants:

·       Ca²⁺ spark initiation: ~10–50 ms

·       Global Ca²⁺ transient: ~100–500 ms

·       Ca²⁺ oscillation frequency in myogenically active SMCs: ~0.1–1 Hz

·       Ca²⁺ wave propagation along a vessel segment: seconds

This stage strongly attenuates anything above ~1–2 Hz in terms of producing graded, summating Ca²⁺ responses. Below this frequency, each pulse can produce a discrete Ca²⁺ transient; above it, responses merge into a sustained elevation. The filter here is approximately a leaky integrator — it accumulates Ca²⁺ signal over time with a decay determined by SERCA pump activity and Ca²⁺ extrusion rates.

Stage 4: Intracellular Ca²⁺ → Vascular Tone Change

This is where the low-pass character becomes most pronounced. The contractile apparatus responds to Ca²⁺/calmodulin with:

·       MLCK activation and cross-bridge cycling: onset ~1–5 seconds

·       Sustained myogenic contraction: tens of seconds to minutes

·       RhoA/ROCK Ca²⁺ sensitisation: develops over seconds, sustained for minutes

·       Vasodilatory response (via NO, prostacyclin, EDHF if endothelium is involved): seconds to minutes

The mechanical output — change in vessel diameter and tone — therefore has a cutoff frequency of roughly 0.01–0.1 Hz (periods of 10 seconds to minutes). This stage almost completely rejects the temporal structure of the FUS pulse train and responds only to the time-averaged Ca²⁺ load delivered over many seconds.

Stage 5: Vascular Tone → Neurovascular Unit Microenvironment

The downstream signalling to neurons adds further low-pass stages:

·       Adenosine accumulation from ATP ectonucleotidase cascade: tens of seconds to minutes to reach neuromodulatory concentrations, clears over minutes

·       K⁺ redistribution via astrocyte Kir4.1 buffering: seconds to minutes

·       NO diffusion into neuropil: seconds, but biological effects on neuronal NO-sensitive channels persist minutes

·       Glymphatic flow changes from altered pulsatility: minutes to tens of minutes

Each of these is a further integrating low-pass stage. By the time the signal reaches the neuron it has been temporally smeared across minutes.

The Complete Filter Cascade

Putting the stages together, the system looks like this:

FUS pulse train
      
[Stage 1: Wall mechanics — cutoff ~200-1000 Hz]
      
[Stage 2: MSC gating kinetics — cutoff ~2-10 Hz, rectifying]
      
[Stage 3: Ca²⁺ dynamics — cutoff ~1-2 Hz, leaky integrator]
      
[Stage 4: Contractile apparatus — cutoff ~0.01-0.1 Hz]
      
[Stage 5: Neurohumoral signalling — cutoff ~0.001-0.01 Hz]
      
Neural excitability change (minutes timescale)

Each stage progressively strips away the temporal fine structure of the FUS input. By Stage 4 onwards, virtually all information about individual pulse timing is lost — what survives is only the time-averaged dose of mechanical stimulation delivered over tens of seconds.

Testable Predictions This Framework Makes

This low-pass filter model generates several sharp predictions that could distinguish it from a neuron-first mechanism:

Prediction 1: Pulse Timing Fine Structure Should Not Matter Beyond a Cutoff

If the dominant mechanism is vasculo-neural, varying the pulse repetition frequency above ~2–10 Hz should produce equivalent neuromodulatory effects as long as the time-averaged intensity is matched. A neuron-first mechanism would predict strong dependence on PRF up to much higher frequencies (~100–1000 Hz, matching neuronal membrane time constants).

Prediction 2: Total Dose Should Predict Effect Better Than Temporal Pattern

For the vascular filter model, the spatial-peak temporal-average intensity × duration (the dose integral) should be the primary predictor of neuromodulatory magnitude. For a neuron-first model, specific temporal patterns (burst frequencies matching neural oscillations, for example) should outperform dose-matched alternatives.

Prediction 3: There Should Be a Minimum Effective Dose Duration

Because the vascular contractile response requires seconds to develop, FUS stimuli shorter than ~1–3 seconds should be substantially less effective per unit energy than longer stimuli — the filter needs time to integrate the input to threshold. A neuron-first mechanism predicts effectiveness scaling differently with duration.

Prediction 4: The Neuromodulatory Effect Should Outlast the Vascular Response

If adenosine accumulation is the final transducer, its clearance time constant (~5–20 minutes) should be measurable as the decay time constant of the behavioural or TMS effect — independent of the FUS parameters used. This would be a strong fingerprint of the adenosine pathway specifically.

Prediction 5: Low-Frequency Amplitude Modulation Should Be More Effective Than Unmodulated CW

If the vessel wall resonance (~100–500 Hz for arterioles) is a real stage in the filter, amplitude-modulated FUS at that frequency should produce greater vascular response per unit acoustic energy than continuous wave or off-resonance modulation — a prediction with no natural equivalent in the neuron-first framework.

An Important Nuance: The Filter Is Nonlinear

The cascade is not a simple linear low-pass filter for two reasons:

Threshold nonlinearity at MSC gating: There is a minimum strain amplitude required for MSC activation — below threshold, the gain of Stage 2 is essentially zero regardless of frequency. This means the filter has an input threshold that interacts with temporal summation — sub-threshold pulses can summate to reach threshold if delivered faster than the Ca²⁺ decay rate, but this only works up to the ~1–2 Hz cutoff of Stage 3.

Myogenic autoregulatory feedback: The vascular response itself changes the mechanical state of the vessel wall — vasoconstriction increases wall stress and shifts the MSC operating point. This feedback loop means the filter characteristics change dynamically as the response develops, potentially producing oscillatory or bistable behaviour rather than simple monotonic integration.

Contrast With a Neuron-First Filter

For completeness, a neuron-first mechanism would predict a filter with:

·       Cutoff frequency ~50–200 Hz (neuronal membrane time constant ~5–20 ms)

·       Sensitivity to specific temporal patterns matching neural oscillation frequencies (gamma ~40 Hz, theta ~8 Hz)

·       Effect duration tracking the stimulus duration much more closely

·       Rapid offset after stimulus cessation (seconds, not minutes)

The fact that published FUS neuromodulation literature shows weak dependence on PRF above ~100 Hz and strong dependence on total duty cycle and duration is already qualitatively consistent with the vasculo-neural low-pass filter model — though this has not, to our knowledge, been framed and tested explicitly in those terms.

Summary

Yes — a vasculo-neural mechanism would act as a multi-stage low-pass filter with an effective cutoff at the level of vascular tone of roughly 0.01–0.1 Hz, meaning the neuromodulatory output is essentially the time-integral of the acoustic dose over tens of seconds, with virtually all temporal fine structure of the pulse train filtered out by the time the signal reaches neurons. This is a distinctive and testable prediction that separates it sharply from neuron-first mechanisms, and the existing FUS literature — while not designed to test it — is largely consistent with it.

__________

 

My Summary 

Putting aside the flattery at the start of each answer, what Claude came up with has given me an epically vast amount to think about. For example, the ongoing dynamic state of vessels in the tFUS target region might be important variables in the efficacy of any vascular coupling, potentially contributing to reproducibility within and between subjects. The current state can be dependent on local neurovascular signaling (i.e. on the amount of neural activity), on the systemic physiology (e.g. the arterial CO2 concentration) and perhaps even on the systolic blood pressure wave. Perhaps the tFUS mechanics entrain the local vasculature over some small window of time. Seeing adenosine among the implicated mechanisms suggests that caffeine intake might be another important variable to control/track in human subjects, as for fMRI. There are all sorts of possibilities.

I'm not sure what I'll do next. I need to re-read Claude's responses two or three more times and then perhaps go after some of the original references to bolster my understanding. If I had a lab doing tFUS I'd perhaps design a couple of experiments to investigate the direct effects of burst duration and envelopes on blood vessels. Hopefully more physiologists will start to look at tFUS and tinker; the neuroscientists would undoubtedly appreciate it, just as they did when people trained in physiology dug into fMRI mechanisms. I can think of a few names. If you're already in the tFUS space, perhaps try to find a physiologist local to you and bug him/her with questions. I doubt you'll regret it.